Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform-Reference-Cited by-同舟云学术

Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform

Published:2023-12 Issue:12 Volume:25 Page:1349-1360
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Trainor Nuala^ORCID,Purpura Kelly A.,Middleton Kevin,Fargo Karen,Hails Lauren,Vicentini-Hogan Michele,McRobie Chase,Daniels Raelyn,Densham Phil,Gardin Paul^ORCID,Fouks Michael,Brayer Hadar,Malka Rivka Gal,Rodin Anastasia,Ogen Tal,Besser Michal J.,Smith Tim,Leonard David,Bryan Adam

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference36 articles.

1. Treatment of patients with metastatic cancer using major histocompatibility complex Class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3;Lu;J. Clin. Oncol.,2017

2. First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: updated results;Berdeja;J. Clin. Oncol.,2017

3. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells;Kebriaei;J. Clin Invest.,2016

4. National Cancer Institute. CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers 2022 https://www.cancer.gov/about-cancer/treatment/research/car-t-cells (accessed May 4, 2023).

5. Global manufacturing of CAR T cell therapy;Levine;Mol. Ther. Methods Clin. Dev.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a robotic cluster for automated and scalable cell therapy manufacturing;Cytotherapy;2024-09

2. Advances in manufacturing chimeric antigen receptor immune cell therapies;Seminars in Immunopathology;2024-08-16

3. The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors;Cancer Letters;2024-06

4. Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy;Molecular Therapy - Methods & Clinical Development;2024-06

5. Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum;Cell Reports Medicine;2024-05